A phase II trial of celecoxib (CX) irinotecan (I), 5-fluorouracil (5FU), and leucovorin (LCV) in patients (pts) with unresectable or metastatic colorectal cancer (CRC). - Blanke,C.D.; Benson,A.B.; Dragovich,T. (Proc Am Soc Clin Oncol, 2002)